HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ye Guo Selected Research

saccharopine

1/2022The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ye Guo Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 01/2008
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2021 - 10/2009
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022 - 09/2012
10Lymphoma (Lymphomas)
07/2021 - 02/2007
10Leukemia
02/2021 - 10/2009
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 07/2014
6T-Cell Lymphoma (Lymphoma, T Cell)
07/2021 - 07/2006
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 10/2009
6Aplastic Anemia (Anemia, Hypoplastic)
01/2021 - 02/2014
5B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 08/2015
5Disease Progression
01/2022 - 01/2008
5Infections
06/2021 - 06/2013
4Squamous Cell Carcinoma of Head and Neck
10/2021 - 02/2011
4Adenocarcinoma of Lung
01/2021 - 01/2019
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 06/2015
4Cardiotoxicity
03/2020 - 05/2016
4Extranodal NK-T-Cell Lymphoma
01/2020 - 10/2008
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2014
3Residual Neoplasm
01/2022 - 07/2015
3Philadelphia Chromosome
02/2021 - 06/2015
3Carcinogenesis
12/2019 - 01/2015
3Breast Neoplasms (Breast Cancer)
05/2016 - 10/2015
3Chromosome Aberrations (Chromosome Abnormalities)
04/2016 - 10/2009
3Adenocarcinoma
06/2015 - 01/2009
3Nasopharyngeal Carcinoma
12/2013 - 05/2008
2Hypoalbuminemia
02/2022 - 01/2020
2Hyperlysinemias (Hyperlysinemia)
01/2022 - 01/2019
2Neutropenia
01/2022 - 11/2020
2Febrile Neutropenia
01/2022 - 11/2020
2Hematologic Diseases (Blood Diseases)
09/2021 - 04/2016
2Carcinoma (Carcinomatosis)
01/2019 - 01/2015
2Neoplasm Metastasis (Metastasis)
10/2018 - 03/2014
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
06/2017 - 12/2013
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2017 - 02/2012
2Circulating Neoplastic Cells
06/2014 - 04/2013
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2009 - 09/2005
2Stomach Neoplasms (Stomach Cancer)
03/2009 - 01/2009
1Anemia
02/2022
1Hyponatremia
01/2022
1Leukopenia
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022

Drug/Important Bio-Agent (IBA)

14Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2005
11Rituximab (Mabthera)FDA Link
04/2022 - 09/2012
8Doxorubicin (Adriamycin)FDA LinkGeneric
03/2020 - 07/2009
7Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 01/2009
6Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 02/2014
6Proteins (Proteins, Gene)FDA Link
12/2020 - 10/2009
5Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2015
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2015
5Biological ProductsIBA
09/2021 - 04/2009
5AnthracyclinesIBA
03/2020 - 05/2016
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2020 - 07/2009
4Etoposide (VP 16)FDA LinkGeneric
07/2021 - 04/2014
4Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2013
4GemcitabineFDA Link
01/2019 - 09/2005
4Vincristine (Oncovin)FDA LinkGeneric
05/2016 - 07/2009
4Prednisone (Sone)FDA LinkGeneric
05/2016 - 07/2009
3Carboplatin (JM8)FDA LinkGeneric
02/2022 - 04/2014
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2019
3Peptides (Polypeptides)IBA
11/2021 - 06/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
07/2021 - 02/2012
3IfosfamideFDA LinkGeneric
07/2021 - 04/2014
3AfatinibIBA
01/2021 - 01/2019
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2020 - 02/2014
3PlatinumIBA
10/2020 - 08/2015
3Keratins (Keratin)IBA
01/2020 - 04/2013
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
10/2019 - 02/2014
3Hemoglobins (Hemoglobin)IBA
02/2019 - 12/2014
2Cetuximab (Erbitux)FDA Link
10/2021 - 08/2015
2Asparaginase (Elspar)FDA Link
07/2021 - 03/2014
2Imatinib Mesylate (Gleevec)FDA Link
03/2021 - 08/2015
2Therapeutic UsesIBA
02/2021 - 10/2014
2Pharmaceutical PreparationsIBA
03/2020 - 04/2011
2Fibrinogen (Factor I)FDA Link
01/2020 - 01/2019
2Oxidoreductases (Dehydrogenase)IBA
01/2019 - 01/2015
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019 - 01/2018
2Docetaxel (Taxotere)FDA Link
06/2017 - 01/2009
2Epirubicin (Ellence)FDA LinkGeneric
05/2016 - 03/2009
2MicroRNAs (MicroRNA)IBA
12/2015 - 10/2015
2polyacrylamideIBA
08/2015 - 10/2009
2Stem Cell FactorIBA
09/2013 - 04/2011
1Immune Checkpoint InhibitorsIBA
02/2022
1130-nm albumin-bound paclitaxelIBA
02/2022
1sintilimabIBA
02/2022
1osimertinibIBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1saccharopineIBA
01/2022

Therapy/Procedure

31Drug Therapy (Chemotherapy)
02/2022 - 09/2005
20Therapeutics
09/2021 - 05/2010
8Radiotherapy
04/2022 - 02/2007
5Induction Chemotherapy
01/2021 - 01/2008
3Neoadjuvant Therapy
02/2022 - 05/2010
3Transplantation
01/2021 - 01/2015
3Salvage Therapy
01/2021 - 01/2008
2Chemoradiotherapy
07/2021 - 06/2017
2VAP-cyclo protocol
01/2017 - 12/2014
2Ligation
04/2016 - 01/2016
2Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 09/2005
1Operative Surgical Procedures
02/2022